SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-22-001478
Filing Date
2022-02-15
Accepted
2022-02-15 16:43:20
Documents
2
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4294
2 POA cbenecchipoa.txt EX-24 1943
  Complete submission text file 0001562180-22-001478.txt   7587
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Benecchi Christopher (Reporting) CIK: 0001881403 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 22639783